Prime Medicine Inc (PRME)
3.345
-0.25
(-6.95%)
USD |
NASDAQ |
Nov 15, 16:00
3.34
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Total Liabilities (Quarterly): 143.28M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 143.28M |
| June 30, 2024 | 63.12M |
| March 31, 2024 | 67.62M |
| December 31, 2023 | 60.78M |
| September 30, 2023 | 45.19M |
| June 30, 2023 | 40.76M |
| Date | Value |
|---|---|
| March 31, 2023 | 38.14M |
| December 31, 2022 | 44.04M |
| September 30, 2022 | 42.56M |
| June 30, 2022 | 46.86M |
| December 31, 2021 | 62.30M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
38.14M
Minimum
Mar 2023
143.28M
Maximum
Sep 2024
59.51M
Average
46.86M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 76.47B |
| Molecular Templates Inc | 19.59M |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 332.78M |
| Shareholders Equity (Quarterly) | 189.50M |
| Current Ratio | 6.497 |